Original Article
Efficiency of Naproxen/Esomeprazole in Association for Osteoarthrosis Treatment in Spain
Eficiencia de la combinación naproxeno/esomeprazol para el tratamiento de la artrosis en España
Margarita Capela, Jesús Tornerob, José Luis Zamoranoc, Itziar Oyagüezd,
, Miguel Ángel Casadod, Joaquín Sánchez-Covisaa, Ángel Lanase
Corresponding author
a Health Economics & Outcomes Research, AstraZeneca Farmacéutica Spain, Madrid, Spain
b Servicio de Reumatología, Hospital General Universitario de Guadalajara, Guadalajara, Spain
c Servicio de Cardiología, Hospital Ramón y Cajal, Madrid, Spain
d Pharmacoeconomics and Outcomes Research Iberia, Madrid, Spain
e Servicio de Aparato Digestivo, Hospital Clínico, CIBERehd, IIS Aragón, Universidad de Zaragoza, Zaragoza, Spain
Read
11416
Timeswas read the article
3178
Total PDF
8238
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 6 | 13 | 19 |
| 2025 5 | 237 | 56 | 293 |
| 2025 4 | 212 | 65 | 277 |
| 2025 3 | 163 | 51 | 214 |
| 2025 2 | 130 | 48 | 178 |
| 2025 1 | 118 | 61 | 179 |
| 2024 12 | 95 | 40 | 135 |
| 2024 11 | 136 | 74 | 210 |
| 2024 10 | 115 | 55 | 170 |
| 2024 9 | 132 | 44 | 176 |
| 2024 8 | 123 | 48 | 171 |
| 2024 7 | 80 | 44 | 124 |
| 2024 6 | 99 | 43 | 142 |
| 2024 5 | 101 | 43 | 144 |
| 2024 4 | 93 | 47 | 140 |
| 2024 3 | 90 | 48 | 138 |
| 2024 2 | 108 | 28 | 136 |
| 2024 1 | 56 | 40 | 96 |
| 2023 12 | 60 | 63 | 123 |
| 2023 11 | 73 | 49 | 122 |
| 2023 10 | 66 | 53 | 119 |
| 2023 9 | 167 | 37 | 204 |
| 2023 8 | 71 | 30 | 101 |
| 2023 7 | 72 | 26 | 98 |
| 2023 6 | 74 | 39 | 113 |
| 2023 5 | 81 | 43 | 124 |
| 2023 4 | 123 | 28 | 151 |
| 2023 3 | 97 | 50 | 147 |
| 2023 2 | 109 | 30 | 139 |
| 2023 1 | 119 | 35 | 154 |
| 2022 12 | 110 | 33 | 143 |
| 2022 11 | 113 | 41 | 154 |
| 2022 10 | 117 | 48 | 165 |
| 2022 9 | 153 | 44 | 197 |
| 2022 8 | 136 | 53 | 189 |
| 2022 7 | 118 | 57 | 175 |
| 2022 6 | 84 | 35 | 119 |
| 2022 5 | 122 | 42 | 164 |
| 2022 4 | 78 | 50 | 128 |
| 2022 3 | 80 | 63 | 143 |
| 2022 2 | 70 | 36 | 106 |
| 2022 1 | 96 | 58 | 154 |
| 2021 12 | 70 | 44 | 114 |
| 2021 11 | 66 | 50 | 116 |
| 2021 10 | 64 | 65 | 129 |
| 2021 9 | 40 | 40 | 80 |
| 2021 8 | 56 | 41 | 97 |
| 2021 7 | 37 | 51 | 88 |
| 2021 6 | 54 | 48 | 102 |
| 2021 5 | 49 | 45 | 94 |
| 2021 4 | 147 | 100 | 247 |
| 2021 3 | 99 | 30 | 129 |
| 2021 2 | 59 | 45 | 104 |
| 2021 1 | 55 | 41 | 96 |
| 2020 12 | 42 | 13 | 55 |
| 2020 11 | 76 | 34 | 110 |
| 2020 10 | 45 | 16 | 61 |
| 2020 9 | 35 | 22 | 57 |
| 2020 8 | 50 | 21 | 71 |
| 2020 7 | 56 | 16 | 72 |
| 2020 6 | 54 | 35 | 89 |
| 2020 5 | 52 | 18 | 70 |
| 2020 4 | 55 | 30 | 85 |
| 2020 3 | 20 | 6 | 26 |
| 2020 2 | 1 | 0 | 1 |
| 2019 7 | 1 | 2 | 3 |
| 2018 5 | 4 | 0 | 4 |
| 2018 4 | 76 | 13 | 89 |
| 2018 3 | 77 | 8 | 85 |
| 2018 2 | 39 | 8 | 47 |
| 2018 1 | 55 | 15 | 70 |
| 2017 12 | 44 | 7 | 51 |
| 2017 11 | 48 | 12 | 60 |
| 2017 10 | 46 | 7 | 53 |
| 2017 9 | 58 | 7 | 65 |
| 2017 8 | 84 | 9 | 93 |
| 2017 7 | 60 | 17 | 77 |
| 2017 6 | 86 | 17 | 103 |
| 2017 5 | 96 | 15 | 111 |
| 2017 4 | 75 | 8 | 83 |
| 2017 3 | 80 | 11 | 91 |
| 2017 2 | 49 | 11 | 60 |
| 2017 1 | 51 | 3 | 54 |
| 2016 12 | 76 | 20 | 96 |
| 2016 11 | 91 | 3 | 94 |
| 2016 10 | 141 | 14 | 155 |
| 2016 9 | 179 | 10 | 189 |
| 2016 8 | 76 | 10 | 86 |
| 2016 7 | 45 | 6 | 51 |
| 2015 12 | 2 | 0 | 2 |
| 2015 9 | 1 | 0 | 1 |
| 2015 8 | 3 | 0 | 3 |
| 2015 7 | 35 | 5 | 40 |
| 2015 6 | 77 | 14 | 91 |
| 2015 5 | 66 | 13 | 79 |
| 2015 4 | 64 | 18 | 82 |
| 2015 3 | 45 | 16 | 61 |
| 2015 2 | 57 | 9 | 66 |
| 2015 1 | 63 | 21 | 84 |
| 2014 12 | 65 | 9 | 74 |
| 2014 11 | 88 | 22 | 110 |
| 2014 10 | 82 | 19 | 101 |
| 2014 9 | 53 | 25 | 78 |
| 2014 8 | 68 | 41 | 109 |
| 2014 7 | 67 | 31 | 98 |
Show all
